CHEMED CORP (CHE) Upgraded by Zacks to OUTPERFORM

Zacks Zacks Investment Research upgraded shares of CHEMED CORP (CHE) from NEUTRAL to OUTPERFORM on February 20, 2014, with a target price of $85.90.

Chemed Corporation is the nation's largest provider of end-of-life hospice care services through its VITAS Healthcare Corporation subsidiary. Chemed also maintains a presence in the residential and commercial repair-and-maintenance industry through two subsidiaries. Roto-Rooter is North America's largest provider of plumbing and drain cleaning services. Service America Network Inc. provides major-appliance and heating/air-conditioning repair, maintenance, and replacement services.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on CHEMED CORP (CHE),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply